ID

16918

Description

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells; ODM derived from: https://clinicaltrials.gov/show/NCT00400556

Link

https://clinicaltrials.gov/show/NCT00400556

Keywords

  1. 8/14/16 8/14/16 -
Uploaded on

August 14, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00400556

Eligibility Multiple Myeloma NCT00400556

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
likely to comply with study protocol
Description

Compliance

Data type

boolean

Alias
UMLS CUI [1]
C1321605
age of 18-70
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
histologically proven multiple myeloma or lymphoma
Description

multiple myeloma or lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0026764
UMLS CUI [2]
C0024299
not currently receiving cytotoxic agents however thalidomide, prednisolone, dexamethasone are allowable
Description

Cytotoxic agents

Data type

boolean

Alias
UMLS CUI [1]
C0304497
multiple myeloma patients must be receiving regular bisphosphonates
Description

Bisphosphonates

Data type

boolean

Alias
UMLS CUI [1]
C0012544
absolute neutrophil count between 1.5 and 10.0 x 10^9/l
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
ecog performance status </= 3
Description

ECOG

Data type

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of at least two months
Description

Life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
written informed consent signed by patient or legally authorised representative
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of other vitamin a preparations within the last 30 days
Description

Vitamin A preparations

Data type

boolean

Alias
UMLS CUI [1]
C0042839
active infection or fever >/= 38.2 degrees celsius
Description

Infection or fever

Data type

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0015967
pregnancy or breast feeding. women of child bearing potential admitted to the trial must take adequate measures to prevent conception (at least two different forms of contraception) and are to undergo a pregnancy test. oral contraception must not include low-dose progestogens
Description

Pregnancy or Breast Feeding, Contraception

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0700589
known allergy to e.coli derived products
Description

Allergy to E. Coli derived products

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0014834
current treatment with tetracycline antibiotics
Description

Tetracycline antibiotics

Data type

boolean

Alias
UMLS CUI [1]
C1744619

Similar models

Eligibility Multiple Myeloma NCT00400556

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Compliance
Item
likely to comply with study protocol
boolean
C1321605 (UMLS CUI [1])
Age
Item
age of 18-70
boolean
C0001779 (UMLS CUI [1])
multiple myeloma or lymphoma
Item
histologically proven multiple myeloma or lymphoma
boolean
C0026764 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
Cytotoxic agents
Item
not currently receiving cytotoxic agents however thalidomide, prednisolone, dexamethasone are allowable
boolean
C0304497 (UMLS CUI [1])
Bisphosphonates
Item
multiple myeloma patients must be receiving regular bisphosphonates
boolean
C0012544 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count between 1.5 and 10.0 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
ECOG
Item
ecog performance status </= 3
boolean
C1520224 (UMLS CUI [1])
Life expectancy
Item
life expectancy of at least two months
boolean
C0023671 (UMLS CUI [1])
Informed consent
Item
written informed consent signed by patient or legally authorised representative
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Vitamin A preparations
Item
use of other vitamin a preparations within the last 30 days
boolean
C0042839 (UMLS CUI [1])
Infection or fever
Item
active infection or fever >/= 38.2 degrees celsius
boolean
C0009450 (UMLS CUI [1])
C0015967 (UMLS CUI [2])
Pregnancy or Breast Feeding, Contraception
Item
pregnancy or breast feeding. women of child bearing potential admitted to the trial must take adequate measures to prevent conception (at least two different forms of contraception) and are to undergo a pregnancy test. oral contraception must not include low-dose progestogens
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
Allergy to E. Coli derived products
Item
known allergy to e.coli derived products
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0014834 (UMLS CUI [1,3])
Tetracycline antibiotics
Item
current treatment with tetracycline antibiotics
boolean
C1744619 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial